← back to search

Stanley J. Szefler

University of Illinois Chicago · US
Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Asthma, Exacerbation, Genome-wide association study, Intensive care medicine, and Omalizumab.
h-index
citations
8,043
works
56
NIH funding
primary concept
email

Recent publications

Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population
The Journal of Allergy and Clinical Immunology In Practice 2024cited by 26position: middledoi
Social Determinants of Health in Asthma Through the Life Course
The Journal of Allergy and Clinical Immunology In Practice 2022cited by 37position: middledoi
The National Heart Lung and Blood Institute Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Alliance
Health Services Research 2022cited by 30position: lastdoi
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions
Journal of Allergy and Clinical Immunology 2021cited by 61position: middledoi
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment
Journal of Allergy and Clinical Immunology 2021cited by 50position: middledoi
Difficult-to-Treat Asthma Management in School-Age Children
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 34position: lastdoi
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma
eScholarship (California Digital Library) 2021cited by 14position: middle
COVID-19 and the impact of social determinants of health
The Lancet Respiratory Medicine 2020cited by 724position: lastdoi
Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden
The Journal of Allergy and Clinical Immunology In Practice 2020cited by 169position: middledoi
Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation
Contemporary Clinical Trials 2020cited by 62position: middledoi
Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis
European Respiratory Journal 2020cited by 37position: middledoi
Heterogeneity of Mild to Moderate Persistent Asthma in Children: Confirmation by Latent Class Analysis and Association with 1-Year Outcomes
The Journal of Allergy and Clinical Immunology In Practice 2020cited by 30position: middledoi
Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR II
The Journal of Allergy and Clinical Immunology In Practice 2020cited by 23position: middledoi
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations
Journal of Biopharmaceutical Statistics 2020cited by 15position: middledoi
An expert consensus framework for asthma remission as a treatment goal
Journal of Allergy and Clinical Immunology 2019cited by 390position: middledoi
Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level
New England Journal of Medicine 2019cited by 122position: middledoi
Symptoms and perception of airway obstruction in asthmatic patients: Clinical implications for use of reliever medications
Journal of Allergy and Clinical Immunology 2019cited by 70position: middledoi
Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma
New England Journal of Medicine 2019cited by 67position: middledoi
Development and initial validation of the Asthma Severity Scoring System (ASSESS)
Journal of Allergy and Clinical Immunology 2019cited by 29position: middledoi
Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation
The Journal of Allergy and Clinical Immunology In Practice 2018cited by 77position: middledoi
Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma
American Journal of Respiratory and Critical Care Medicine 2017cited by 249position: middledoi
Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience
Journal of Allergy and Clinical Immunology 2017cited by 158position: middledoi
Race is associated with differences in airway inflammation in patients with asthma
Journal of Allergy and Clinical Immunology 2017cited by 54position: middledoi
Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index
Journal of Allergy and Clinical Immunology 2017cited by 43position: lastdoi
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma
New England Journal of Medicine 2016cited by 599position: middledoi
Individualized therapy for persistent asthma in young children
Journal of Allergy and Clinical Immunology 2016cited by 295position: lastdoi
The nasal methylome and childhood atopic asthma
Journal of Allergy and Clinical Immunology 2016cited by 165position: middledoi
Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma
New England Journal of Medicine 2016cited by 80position: middledoi
Genetics and Genomics of Longitudinal Lung Function Patterns in Individuals with Asthma
American Journal of Respiratory and Critical Care Medicine 2016cited by 26position: middledoi
A summary of the new GINA strategy: a roadmap to asthma control
European Respiratory Journal 2015cited by 786position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

William W. Busse · University of Wisconsin–Madison12 papers (2012–2019)Andrew H. Liu · Children's Hospital Colorado9 papers (2012–2017)Stephen J. Teach · University of Vermont8 papers (2012–2017)Peter J. Gergen · National Institute of Allergy and Infectious Diseases8 papers (2012–2019)Wayne J. Morgan · University of Illinois Chicago8 papers (2012–2020)Christine A. Sorkness · University of Wisconsin–Madison8 papers (2012–2016)Fernando D. Martínez · University of Illinois Chicago7 papers (2012–2020)David T. Mauger · University of Illinois Chicago7 papers (2013–2020)Robert F. Lemanske · University of Wisconsin–Madison7 papers (2013–2020)Agustin Calatroni · Thermo Fisher Scientific (United States)7 papers (2012–2017)Elliot Israel · Harvard University6 papers (2012–2019)Jeremy Wildfire · Gilead Sciences (United States)6 papers (2012–2017)Rebecca S. Gruchalla · Southwestern Medical Center6 papers (2012–2017)Robert S. Zeiger · Kaiser Permanente5 papers (2013–2020)Anne M. Fitzpatrick · Emory University5 papers (2013–2021)Meyer Kattan · Columbia University5 papers (2013–2017)Jacqueline A. Pongracic · University of Illinois Chicago5 papers (2012–2020)Leonard B. Bacharier · University of Illinois Chicago5 papers (2013–2020)Alkis Togias · University of Colorado Denver5 papers (2012–2017)Herman Mitchell · California University of Pennsylvania5 papers (2012–2017)